The blood-spinal cord barrier: morphology and clinical implications - Wikidata - wikimedia - TriplyDB

The blood-spinal cord barrier: morphology and clinical implications

The blood-spinal cord barrier: morphology and clinical implications

http://www.wikidata.org/entity/Q28240807

about

Aquaporin 4 and neuromyelitis optica Cytokine and Growth Factor Activation In Vivo and In Vitro after Spinal Cord Injury The Immunology of Neuromyelitis Optica-Current Knowledge, Clinical Implications, Controversies and Future Perspectives Therapeutic Hypothermia in Spinal Cord Injury: The Status of Its Use and Open Questions Mechanism of West Nile virus neuroinvasion: a critical appraisal Blood-CNS Barrier Impairment in ALS patients versus an animal model A perspective on the role of class III semaphorin signaling in central nervous system trauma Stem cell therapy for central nerve system injuries: glial cells hold the key ABC transporter function and regulation at the blood-spinal cord barrier Hello from the Other Side: How Autoantibodies Circumvent the Blood-Brain Barrier in Autoimmune Encephalitis.17β-Estradiol Ameliorates Tight Junction Disruption via Repression of MMP Transcription.An atypical role for the myeloid receptor Mincle in central nervous system injury The effects of local and general hypothermia on temperature profiles of the central nervous system following spinal cord injury in rats.Matrix metalloproteinase-12 deficiency ameliorates the clinical course and demyelination in Theiler's murine encephalomyelitis.Possible association between expression of chemokine receptor-2 (CCR2) and amyotrophic lateral sclerosis (ALS) patients of North India.The blood-brain barrier in health and disease.Modelling the endothelial blood-CNS barriers: a method for the production of robust in vitro models of the rat blood-brain barrier and blood-spinal cord barrier.Plasma peptide biomarker discovery for amyotrophic lateral sclerosis by MALDI-TOF mass spectrometry profiling Central administration of C-X-C chemokine receptor type 4 antagonist alleviates the development and maintenance of peripheral neuropathic pain in mice.Spinal cord injury is related to an increased risk of multiple sclerosis: a population-based, propensity score-matched, longitudinal follow-up study.Identification of trichlormethiazide as a Mdr1a/b gene expression enhancer via a dual secretion-based promoter assay.The Neuroprotective Effect of Tetramethylpyrazine Against Contusive Spinal Cord Injury by Activating PGC-1α in Rats.Not just the brain: methamphetamine disrupts blood-spinal cord barrier and induces acute glial activation and structural damage of spinal cord cells.Selective increase of two ABC drug efflux transporters at the blood-spinal cord barrier suggests induced pharmacoresistance in ALS.Effects of peripheral inflammation on the blood-spinal cord barrier.Antibody profiling identifies novel antigenic targets in spinal cord injury patients.Blood-spinal cord barrier pericyte reductions contribute to increased capillary permeability Terminal decline in motor function.Retinoic Acid Induced-Autophagic Flux Inhibits ER-Stress Dependent Apoptosis and Prevents Disruption of Blood-Spinal Cord Barrier after Spinal Cord Injury.A critical evaluation of drug delivery from ligand modified nanoparticles: Confounding small molecule distribution and efficacy in the central nervous system.Heterogeneity of the blood-brain barrier Phenylbutyrate prevents disruption of blood-spinal cord barrier by inhibiting endoplasmic reticulum stress after spinal cord injury.Blocking neurogenic inflammation for the treatment of acute disorders of the central nervous system.Epidermal growth factor attenuates blood-spinal cord barrier disruption via PI3K/Akt/Rac1 pathway after acute spinal cord injury.Neurovascular unit in chronic pain.ALS and oxidative stress: the neurovascular scenario Gene expression comparison reveals distinct basal expression of HOX members and differential TNF-induced response between brain- and spinal cord-derived microvascular endothelial cells.Spinal cord pathology in chronic experimental Toxoplasma gondii infection.The cross-talk between autophagy and endoplasmic reticulum stress in blood-spinal cord barrier disruption after spinal cord injury.Neural regenerative strategies incorporating biomolecular axon guidance signals.

P2860

Q24613666-14690282-1A45-4557-BBE3-1841398F7AA6 Q26740237-E0624367-FACF-4B14-9D7A-14A7BE733473 Q26767391-532213A1-1DA8-4EA1-9ADD-6F7ED0A38D63 Q26799349-D573272F-9DD0-4B85-9200-3B4EEEDCEA2F Q27025556-FACC2029-2C8A-4780-911C-2640D9023090 Q27026792-41A2069F-E0D3-43FD-9628-9B8275F1C459 Q28251368-16F3A673-F82A-4C9C-B307-21B0DF2DCD9A Q28394140-59AFFC40-42B8-4CCB-BF6A-54615ECF97F3 Q28573125-FFF7A718-9D5A-4FEC-AA00-94A519F167B3 Q33586199-FE4F538E-B1E4-4C9F-B2BE-E9F82BE4C932 Q33631538-38EB556E-B84B-4D30-ACFA-A88E6C6987C1 Q33727617-CFCC4015-DFCA-4683-9023-A13A053DFF82 Q34116927-29F6577C-0D04-48B5-9982-4CC7C8CE5016 Q34136881-0559F01B-A113-4085-8AD3-3F73355056A7 Q34299611-E87F30EE-8B03-4071-8137-2479345AE017 Q34320420-A4A8199C-7391-42CF-8E71-410A42CBBB3A Q34775079-32FCFEBE-E13F-49FA-B72C-11EA6F8A88D4 Q35041471-60E33BAA-03CF-4DB4-A944-F2C930774AC3 Q35224084-C03EFFA4-01E7-450D-8471-2A74E0326DAF Q35541423-71942894-456D-4398-811C-F7F149C260ED Q35563239-E154AB4D-E6B8-47B7-96BB-60970952B649 Q35825868-77B2BAC6-7223-4CC2-AA31-1398DE9AF548 Q35933491-F6331EFE-DBD8-4B9A-B902-F30B81EA19FF Q36007494-B64CE913-E7F8-44D6-BEA2-A13D2CBD55A3 Q36123303-919EC0AD-E30E-46D1-9387-0C4783D3F4A9 Q36130272-28D4EC6A-DFB2-4F2A-BFAC-8167E92A388C Q36296333-378D374E-8575-48D6-9474-A35242AAFA37 Q36346662-2C791C7F-77D2-40CB-8093-4C1BD6D959F9 Q36372454-070D1E80-8971-4564-91FE-EF39AD6CD8E0 Q36396207-85B814EF-06D8-4420-9781-7D3408B1198C Q36812384-016A71FE-F7CD-46CD-9E59-F0E4B945ACF8 Q36879615-F53C52B1-16CA-4AAB-B12A-83077FEA7007 Q36925594-93AAC5DC-FD39-4073-8CBF-95BF3451E59F Q36942359-8168365F-52A4-4753-B03B-4917398EB9D6 Q36942721-3D6666F1-7BF5-4562-9801-7174E4161FD5 Q37400451-2B9F3FC6-E998-4FB6-8377-C225FFAA0CB8 Q37408854-6E66337A-DBCF-4056-BAF5-4BBF40B63B36 Q37640229-A45AA95A-CE79-462C-9E42-461EE8A68AF6 Q37702151-D15B2FAA-62CC-47D1-9308-F5EEB7CAEA09 Q37973260-B1FE87BE-025F-4EB5-A2D1-F4F03E028AA6

P2860

The blood-spinal cord barrier: morphology and clinical implications

http://www.wikidata.org/entity/Q28240807

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

The blood-spinal cord barrier: morphology and clinical implications

@ast

The blood-spinal cord barrier: morphology and clinical implications

@en

The blood-spinal cord barrier: morphology and clinical implications

@nl

type

label

The blood-spinal cord barrier: morphology and clinical implications

@ast

The blood-spinal cord barrier: morphology and clinical implications

@en

The blood-spinal cord barrier: morphology and clinical implications

@nl

prefLabel

The blood-spinal cord barrier: morphology and clinical implications

@ast

The blood-spinal cord barrier: morphology and clinical implications

@en

The blood-spinal cord barrier: morphology and clinical implications

@nl

P1433

Q28240807-98F41C59-9171-4774-B00A-7E9E4D19CE23

P1476

Q28240807-D24499CF-8C95-4100-A98B-E775D840AE0B

P2093

Q28240807-9B7CBB70-B750-464B-AA05-4C2E04E894F7

Q28240807-A0F70F74-B88F-428F-B764-A0E02BA2F286

Q28240807-D0FCA570-D8A6-4BE0-94BF-F52CC5985801

Q28240807-E7E4CCF8-A4A2-4683-88E8-F872AB609FA9

P2860

Q28240807-03554AF0-2E8A-40EB-8127-A299086E7A45

Q28240807-058FBA9C-8422-4CA6-828A-8CBDF6902A5C

Q28240807-05D435E9-F0DF-4B39-BE24-BBC010120DD1

Q28240807-070EC97C-EEF5-47E3-B317-1A446AABF968

Q28240807-07DC7EC9-17C6-4CFC-88ED-AD3E2D82FCB7

Q28240807-0A592C28-D6FA-43ED-8CA4-A14B9717638D

Q28240807-10779A88-B2A9-4CA9-8448-537D642612C9

Q28240807-14D6DF52-9FA5-461E-A123-1890082A6B3B

Q28240807-1786B88F-08F2-4864-8168-F4DA99874078

Q28240807-1A3AA0F3-A939-444E-BB3C-26124FE3119A

P304

Q28240807-A1798D5C-4C6C-40CF-91E0-F8885029E288

P31

Q28240807-34CE2147-B5F0-4B0A-852D-E864CEC08537

P3181

Q28240807-47C22AE0-77AE-4556-9918-5B02874B977D

P356

Q28240807-4BC1D70F-D1CF-49D3-B7C6-977344EF4753

P407

Q28240807-926AF157-4090-4E0B-9C98-6F48ED6E48BC

P433

Q28240807-3A5ADC0F-33DD-4C41-B0D9-92A2B07D6226

P478

Q28240807-FAB32370-6B65-46F0-B2EE-31BEFA341007

P577

Q28240807-91701BC1-3282-4C70-8B2B-6D32673EF536

P5875

Q28240807-9EA7A597-561A-4166-94C3-D482449A88E0

P698

Q28240807-15461123-E4F5-4765-A89F-CE40D78DF6E3

P3181

P356

P1433

Annals of Neurology

P1476

The blood-spinal cord barrier: morphology and clinical implications

@en

P2093

Betty Alajajian

http://www.w3.org/2001/XMLSchema#string

Daniela Jezova

http://www.w3.org/2001/XMLSchema#string

Murat Digicaylioglu

http://www.w3.org/2001/XMLSchema#string

Viktor Bartanusz

http://www.w3.org/2001/XMLSchema#string

P2860

Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD1 mice modeling ALS

Multifunctional Nanocarriers for diagnostics, drug delivery and targeted treatment across blood-brain barrier: perspectives on tracking and neuroimaging

Neuromyelitis optica pathogenesis and aquaporin 4

Intranasal delivery bypasses the blood-brain barrier to target therapeutic agents to the central nervous system and treat neurodegenerative disease

Inhibiting epidermal growth factor receptor improves structural, locomotor, sensory, and bladder recovery from experimental spinal cord injury.

Astrocyte-endothelial interactions at the blood-brain barrier

Spinal cord repair strategies: why do they work?

A simple fluorescence technique to stain the plasma membrane of human neutrophils

Fluorescence imaging of blood-brain barrier disruption

Reduction of circulating endothelial cells in peripheral blood of ALS patients

P304

194-206

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

555747

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/ANA.22421

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

70

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51220556

http://www.w3.org/2001/XMLSchema#string

P698

21674586

http://www.w3.org/2001/XMLSchema#string